Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systematic reviews

Review

Abstract: Background: Patients with advanced pancreatic cancer (PC) have a high risk of dying in the short or

Palabras claves:

antineoplastic agents, immunotherapy, Pancreatic neoplasms, Review literature as topic

Autores:

Acosta-Dighero R., Antequera A., Auladell-Rispau A., Bonfill X., Daniel Simancas-Racines, Dorantes-Romandía R., Gutiérrez M., Jesus Quintana M.A., Leache L., Meade A.G., Pérez-Bracchiglione J., Requeijo C., Ricardo Hidalgo-Ottolenghi, Rodríguez-Grijalva G., Saiz L.C., Salas-Gama K., Salazar J., Santero M., Sola I., Urrutia G.

Fuentes:

scopus